The clinical features of PD with PLA2G6 mutations generally are levodopa responsiveness, dystonia, gait impairment, speech difficulties, spasticity, myoclonus, and an association with neuropsychiatric and cognitive disorders [47]. The gene discussed is PLA2G6; the disease is Dystonia.